This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names | The Motley Fool

This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.

By Deep Scout · March 18, 2026 · 1 min read

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names | The Motley Fool

dftx
292d7c56-081b-4d0b-9776-5da7bfe8476f
coveragefilings

Source: The Motley Fool

This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.

Similar Topics

Related Posts

This Staffing Stock Has Plunged 56% in a Year, but Does a Nearly $10 Million Buy Signal a Turnaround Looming? | The Motley Fool

Top Holding at 10%: Why a Nearly $60 Million Move Into This Oilfield Stock Stands Out | The Motley Fool

This Energy Stock Returned $131 Million to Shareholders Last Quarter, but One Fund Still Sold Off $48 Million in Shares | The Motley Fool

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain | The Motley Fool

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet?

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish | The Motley Fool

What to Know About a $12 Million Bet Targeting a Packaging Firm Up 17% This Year | The Motley Fool

Why This Investor Bet $7 Million More on a Packaging Company Lagging the S&P 500 by 6 Points | The Motley Fool

Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points | The Motley Fool

What Investors Should Know About This $8 Million Tech ETF Sale Last Quarter

Trending on ShareHub

The System Design Primer

Just shipped my first open-source project!

OpenAI Blog

Building Accessible Web Applications: A Practical Guide

Rapper Lil Poppa dead at 25, days after releasing new music

write-for-us

Before the Coffee Gets Cold: Heartfelt Story of Time Travel and Second Chances

Best DoorDash Promo Code Reddit Finds for Top Discounts

Premium SEO Services That Boost Rankings & Revenue | VirtualSEO.Expert

NBC under fire for commentary about Team USA women's hockey team

Where to Watch The Nanny: Streaming and Online Viewing Options

How Much Is Kindle Unlimited? Subscription Cost and Plan Details

Russian skater facing backlash for comment about Amber Glenn

Google News

Understanding Modern JavaScript Frameworks in 2026

Latest on ShareHub

Yumnam Khemchand Singh Biography, Political Career, and Achievements

Pakistan to Pause Afghanistan Airstrikes for Eid

Justice Department blocked release of secret Epstein drug probe file, Sen. Ron Wyden says

Google News

Google News

Patreon CEO calls AI companies' fair use argument 'bogus,' says creators should be paid | TechCrunch

The Trade Desk Stock Drops. 2 Downgrades Make a Bad Year Worse.

Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.

Tietosuojavalintasi

Tietosuojavalintasi

Tietosuojavalintasi

Tietosuojavalintasi

Tietosuojavalintasi

iOS 26.4 upgrades one of my most-used Control Center features in a big way - 9to5Mac

Gold And Silver Prices Hit One-Month Lows—Here’s Why Iran War Isn’t Raising Metals Prices

Markwayne Mullin Slammed For ‘Anger Issues’ In Testy Confirmation Hearing

Ubiquiti Networks Inc stock hits all-time high of 805.35 USD

MDA Space wins $32M contract for space surveillance systems

UBS upgrades Knight-Swift on tightening truck supply, higher freight rates

Form 6K U Power Ltd For: 18 March

Browse Topics

Around the Network

Yumnam Khemchand Singh Biography, Political Career, and Achievements

Pakistan to Pause Afghanistan Airstrikes for Eid

Justice Department blocked release of secret Epstein drug probe file, Sen. Ron Wyden says

Google News

Google News

Patreon CEO calls AI companies' fair use argument 'bogus,' says creators should be paid | TechCrunch

The Trade Desk Stock Drops. 2 Downgrades Make a Bad Year Worse.

Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.

Tietosuojavalintasi

Tietosuojavalintasi

Tietosuojavalintasi

Tietosuojavalintasi